Does IMATINIB Cause Therapy non-responder? 534 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 534 reports of Therapy non-responder have been filed in association with IMATINIB (Imatinib). This represents 1.2% of all adverse event reports for IMATINIB.
534
Reports of Therapy non-responder with IMATINIB
1.2%
of all IMATINIB reports
159
Deaths
82
Hospitalizations
How Dangerous Is Therapy non-responder From IMATINIB?
Of the 534 reports, 159 (29.8%) resulted in death, 82 (15.4%) required hospitalization, and 17 (3.2%) were considered life-threatening.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IMATINIB. However, 534 reports have been filed with the FAERS database.
What Other Side Effects Does IMATINIB Cause?
Death (9,708)
Drug ineffective (2,628)
Nausea (2,379)
Diarrhoea (2,203)
Fatigue (1,810)
Malignant neoplasm progression (1,716)
Vomiting (1,599)
Malaise (1,361)
Drug intolerance (1,354)
Drug resistance (1,293)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which IMATINIB Alternatives Have Lower Therapy non-responder Risk?
IMATINIB vs IMBRUVICA
IMATINIB vs IMDEVIMAB
IMATINIB vs IMEGLIMIN
IMATINIB vs IMETELSTAT
IMATINIB vs IMIDAPRIL